The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation.
Flavia PeciLinde DekkerAnna PagliaroRuben van BoxtelStefan NierkensMirjam E BelderbosPublished in: Bone marrow transplantation (2022)
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative therapy for patients with a variety of malignant and non-malignant diseases. Despite its life-saving potential, HCT is associated with significant morbidity and mortality. Reciprocal interactions between hematopoietic stem cells (HSCs) and their surrounding bone marrow (BM) niche regulate HSC function during homeostatic hematopoiesis as well as regeneration. However, current pre-HCT conditioning regimens, which consist of high-dose chemotherapy and/or irradiation, cause substantial short- and long-term toxicity to the BM niche. This damage may negatively affect HSC function, impair hematopoietic regeneration after HCT and predispose to HCT-related morbidity and mortality. In this review, we summarize current knowledge on the cellular composition of the human BM niche after HCT. We describe how pre-HCT conditioning affects the cell types in the niche, including endothelial cells, mesenchymal stromal cells, osteoblasts, adipocytes, and neurons. Finally, we discuss therapeutic strategies to prevent or repair conditioning-induced niche damage, which may promote hematopoietic recovery and improve HCT outcome.
Keyphrases
- bone marrow
- stem cells
- cell cycle arrest
- endothelial cells
- mesenchymal stem cells
- high dose
- oxidative stress
- stem cell transplantation
- high glucose
- healthcare
- cell therapy
- single cell
- low dose
- spinal cord
- pi k akt
- squamous cell carcinoma
- metabolic syndrome
- radiation therapy
- adipose tissue
- risk assessment
- rectal cancer
- drug induced
- hematopoietic stem cell
- wound healing
- diabetic rats
- insulin resistance
- prognostic factors
- induced pluripotent stem cells
- signaling pathway
- human health